Prof Wilhelm to step down from Wilex
This article was originally published in Scrip
Executive Summary
Wilex co-founder Professor Olaf G Wilhelm will step down as chief executive officer of the company and chair of the executive management board when his director's contract expires on 31 March 2014. Wilex said Professor Wilhelm would leave the firm "in view of the future direction of the company and the necessary adjustments by mutual consent with the supervisory board." Professor Wilhelm helped found the Munich, Germany-based company in 1997 and has served as CEO since 2001. He will be replaced by current chief financial officer Dr Jan Schmidt-Brand – effective 1 April 2014. The company said this decision reflected the re-positioning of Wilex, which is planning to focus on its ADC technology and push the commercialization of clinical development projects with a team of approximately 50 employees with emphasis in Ladenburg.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.